Christine Mikail
Board Member
Neurogene Inc. (NGNE)Equibles does not estimate personal net worth.
Get an email with a short summary when Neurogene Inc. publishes a filing, an earnings call transcript or a press release.
Get NGNE alertsAbout Christine Mikail
Christine Mikail is recorded as Board Member at Neurogene Inc. (NGNE) since April 20, 2026 and CFO at Neurogene Inc. (NGNE). Neurogene Inc. reported in an 8-K filed April 20, 2026 that Christine Mikail was appointed Class II director, effective April 20, 2026. Neurogene Inc. reported in an 8-K filed December 19, 2023 that Christine Mikail was appointed President and Chief Financial Officer, effective December 18, 2023. The proxy statement of Neurogene Inc. reports total compensation of $2,754,458 for Christine Mikail in fiscal 2025, including a base salary of $556,000. Disclosed compensation is on record for 4 fiscal years. Neurogene Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Neurogene Inc. includes David J. Main (CEO), Donna M. Cochener (CEO), Rachel McMinn (CEO, Chairman and Board Member) and 7 others.
“Effective as of April 20, 2026, the Board of Directors (the "Board") of Neurogene Inc. (the "Company"), upon recommendation of the Board's Nominating and Corporate Governance Committee (the "Nominating Committee"), took action pursuant to the Company's Amended and Restated Bylaws to expand the Board to seven directors and appoint Christine Mikail, the Company's President and Chief Financial Officer, to fill the vacancy created by that expansion.”
“Immediately after the effective time the Merger on December 18, 2023, the Board appointed Rachel McMinn as the Company's Chief Executive Officer and Christine Mikail as the Company's President and Chief Financial Officer, each to serve at the discretion of the Board.”
Affiliation history
-
Current
2026-04-20–present
-
Current
Company network
Leadership on record at Neurogene Inc.
- David J. Main CEO
- Donna M. Cochener CEO
- Rachel McMinn CEO, Chairman, Board Member
- Christine Mikail Cvijic CFO
- Jonathan Drachman CFO
- Robert Ho CFO
- Sean Smith CFO, Chief Accounting Officer
- Donna Cochener General Counsel
- Cory Freedland Board Member
- Keith Woods Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Neurogene Inc. (NGNE) | President and Chief Financial Officer | $556,000 | $2,754,458 |
| 2024 | Neurogene Inc. (NGNE) | President and Chief Financial Officer | $515,000 | $3,362,174 |
| 2023 | Neurogene Inc. (NGNE) | President and Chief Financial Officer | $455,787 | $1,132,484 |
| 2022 | Neurogene Inc. (NGNE) | President and Chief Financial Officer | $436,160 | $611,714 |